1. Academic Validation
  2. Osteocytic FSH inhibition rescues bone mass and boosts fracture healing in ovariectomized mice

Osteocytic FSH inhibition rescues bone mass and boosts fracture healing in ovariectomized mice

  • Life Sci. 2025 Nov 27:385:124121. doi: 10.1016/j.lfs.2025.124121.
Zemin Liu 1 Mingxin Sun 2 Hongjie Zhou 1 Liben Cheng 3 Xiaoli Li 2 Bin Chen 1 Chaoqi Wang 1 Chao Li 1 Dong Wang 1 Yan Li 1 Juan Li 4 Yonghong Zhang 5
Affiliations

Affiliations

  • 1 Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
  • 2 School of Basic Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.
  • 3 School of Basic Medicine, Shanxi Medical University, Taiyuan, Shanxi, China; Department of Pathology and Physiology, School of Basic Medicine, Peking University, Peking, China.
  • 4 Department of Ultrasound, Second Hospital of Shanxi Medical University, Taiyuan, 030001, China.
  • 5 Department of Orthopaedics, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Electronic address: [email protected].
Abstract

Aims: Postmenopausal osteoporosis significantly increases fragility fracture risk. While menopausal estrogen decline coincides with rising follicle-stimulating hormone (FSH), the role of circulating FSH in bone loss remains unclear. This study investigates the direct function of FSH and FSH Receptor (FSHR) in bone, focusing on osteocyte-mediated mechanisms.

Materials and methods: To probe FSHR function, osteocyte-specific Fshr knockout mice (Dmp1-CreERT; Fshrfl/fl) were generated. Following ovariectomy, Fshr deletion was induced with tamoxifen. We performed RNA-sequencing on femoral cortical bone, validated by digital PCR and ELISA. In vitro assays assessed FSH's effect on PI3K/Akt signaling and osteogenic mineralization. Fracture healing and biomechanics were evaluated using a closed femoral fracture model and three-point bending.

Key findings: Osteocyte-specific Fshr knockout enhanced bone mineralization, resorption, and formation-resorption coupling, activating the PI3K/Akt pathway. Fshr deletion blocked FSH-mediated PI3K/Akt inhibition and restored osteogenic mineralization in vitro. Knockout mice showed accelerated callus maturation and improved biomechanical healing post-fracture.

Significance: We identify osteocytes as direct FSH target cells. Osteocyte Fshr deletion promotes bone turnover and accelerates fracture repair in ovariectomized mice by enhancing PI3K/Akt signaling. These findings reveal a new pathophysiological mechanism for postmenopausal osteoporosis and suggest a promising therapeutic strategy targeting FSHR.

Keywords

Bone formation; Bone resorption; Follicle-stimulating hormone; Fracture repair; Ovariectomy; Postmenopausal osteoporosis.

Figures
Products